183 related articles for article (PubMed ID: 35486397)
21. Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration.
Illán-Gala I; Falgàs N; Friedberg A; Castro-Suárez S; Keret O; Rogers N; Oz D; Nigro S; Quattrone A; Quattrone A; Wolf A; Younes K; Santos-Santos M; Borrego-Écija S; Cobigo Y; Dols-Icardo O; Lladó A; Sánchez-Valle R; Clarimon J; Blesa R; Alcolea D; Fortea J; Lleó A; Grinberg LT; Spina S; Kramer JH; Rabinovici GD; Boxer A; Gorno Tempini ML; Miller BL; Seeley WW; Rosen HJ; Perry DC
JAMA Netw Open; 2021 Mar; 4(3):e211290. PubMed ID: 33704477
[TBL] [Abstract][Full Text] [Related]
22. Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn).
Saito Y; Kamagata K; Wijeratne PA; Andica C; Uchida W; Takabayashi K; Fujita S; Akashi T; Wada A; Shimoji K; Hori M; Masutani Y; Alexander DC; Aoki S
Front Neurol; 2022; 13():814768. PubMed ID: 35280291
[TBL] [Abstract][Full Text] [Related]
23. Superior cerebellar peduncle atrophy of progressive supranuclear palsy on phase difference enhanced imaging: a comparison with Parkinson's disease.
Miyata M; Kakeda S; Yoneda T; Ide S; Okada K; Adachi H; Korogi Y
Neuroradiology; 2023 Apr; 65(4):719-727. PubMed ID: 36670276
[TBL] [Abstract][Full Text] [Related]
24. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.
Sakurai K; Imabayashi E; Tokumaru AM; Hasebe S; Murayama S; Morimoto S; Kanemaru K; Takao M; Shibamoto Y; Matsukawa N
Neuroimage Clin; 2015; 7():605-10. PubMed ID: 26082887
[TBL] [Abstract][Full Text] [Related]
25. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
[TBL] [Abstract][Full Text] [Related]
26. Progression of brain atrophy in PSP and CBS over 6 months and 1 year.
Dutt S; Binney RJ; Heuer HW; Luong P; Attygalle S; Bhatt P; Marx GA; Elofson J; Tartaglia MC; Litvan I; McGinnis SM; Dickerson BC; Kornak J; Waltzman D; Voltarelli L; Schuff N; Rabinovici GD; Kramer JH; Jack CR; Miller BL; Rosen HJ; Boxer AL;
Neurology; 2016 Nov; 87(19):2016-2025. PubMed ID: 27742814
[TBL] [Abstract][Full Text] [Related]
27. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.
Soliveri P; Monza D; Paridi D; Radice D; Grisoli M; Testa D; Savoiardo M; Girotti F
Neurology; 1999 Aug; 53(3):502-7. PubMed ID: 10449111
[TBL] [Abstract][Full Text] [Related]
28. Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.
Tsai RM; Miller Z; Koestler M; Rojas JC; Ljubenkov PA; Rosen HJ; Rabinovici GD; Fagan AM; Cobigo Y; Brown JA; Jung JI; Hare E; Geldmacher DS; Natelson-Love M; McKinley EC; Luong PN; Chuu EL; Powers R; Mumford P; Wolf A; Wang P; Shamloo M; Miller BL; Roberson ED; Boxer AL
JAMA Neurol; 2020 Feb; 77(2):215-224. PubMed ID: 31710340
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism.
Mostile G; Nicoletti A; Cicero CE; Cavallaro T; Bruno E; Dibilio V; Luca A; Sciacca G; Raciti L; Contrafatto D; Chiaramonte I; Zappia M
Neurol Sci; 2016 Apr; 37(4):591-5. PubMed ID: 26820655
[TBL] [Abstract][Full Text] [Related]
30. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
[TBL] [Abstract][Full Text] [Related]
31. Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.
Sakurai K; Tokumaru AM; Shimoji K; Murayama S; Kanemaru K; Morimoto S; Aiba I; Nakagawa M; Ozawa Y; Shimohira M; Matsukawa N; Hashizume Y; Shibamoto Y
Neuroradiology; 2017 May; 59(5):431-443. PubMed ID: 28386688
[TBL] [Abstract][Full Text] [Related]
32. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
Paviour DC; Price SL; Stevens JM; Lees AJ; Fox NC
Neurology; 2005 Feb; 64(4):675-9. PubMed ID: 15728291
[TBL] [Abstract][Full Text] [Related]
33. Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome.
Whiteside DJ; Street D; Murley AG; Jones PS; Malpetti M; Ghosh BCP; Coyle-Gilchrist I; Gerhard A; Hu MT; Klein JC; Leigh PN; Church A; Burn DJ; Morris HR; Rowe JB; Rittman T
Hum Brain Mapp; 2023 Aug; 44(11):4239-4255. PubMed ID: 37269181
[TBL] [Abstract][Full Text] [Related]
34. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cortical atrophy between progressive supranuclear palsy and corticobasal degeneration by hemispheric surface display of MR images.
Taki M; Ishii K; Fukuda T; Kojima Y; Mori E
AJNR Am J Neuroradiol; 2004; 25(10):1709-14. PubMed ID: 15569735
[TBL] [Abstract][Full Text] [Related]
36. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy.
Walter U; Dressler D; Wolters A; Probst T; Grossmann A; Benecke R
Neurology; 2004 Aug; 63(3):504-9. PubMed ID: 15304582
[TBL] [Abstract][Full Text] [Related]
37. Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.
Morelli M; Arabia G; Messina D; Vescio B; Salsone M; Chiriaco C; Perrotta P; Rocca F; Cascini GL; Barbagallo G; Nigro S; Quattrone A
Mov Disord; 2014 Apr; 29(4):488-95. PubMed ID: 24573655
[TBL] [Abstract][Full Text] [Related]
38. Progressive Supranuclear Palsy and Corticobasal Degeneration.
Coughlin DG; Dickson DW; Josephs KA; Litvan I
Adv Exp Med Biol; 2021; 1281():151-176. PubMed ID: 33433875
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism.
Heim B; Mangesius S; Krismer F; Wenning GK; Hussl A; Scherfler C; Gizewski ER; Schocke M; Esterhammer R; Quattrone A; Poewe W; Seppi K
Parkinsonism Relat Disord; 2021 Jan; 82():87-91. PubMed ID: 33271461
[TBL] [Abstract][Full Text] [Related]
40. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
